Aclaris therapeutics, inc. (ACRS)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Sep'14
Revenue, net

4,371

4,227

8,350

8,485

6,296

6,151

6,596

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

Costs and expenses:
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cost of revenue

-

-

-

-

4,569

4,329

3,668

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

Cost of revenue

0

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gross profit

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Research and development

54,700

64,899

71,510

70,516

66,878

60,841

51,982

47,657

41,638

35,804

33,544

29,842

31,713

33,476

28,935

31,180

23,137

15,339

15,034

0

0

0

Sales and marketing

-

-

-6,377

-6,426

-

170

16,566

20,060

9,880

85

0

0

0

-

-

-

-

-

-

-

-

-

General and administrative

25,892

27,156

27,249

26,664

26,795

25,591

26,042

24,467

21,488

18,948

14,817

13,901

11,912

11,796

12,807

10,390

8,040

5,328

3,493

0

0

0

Goodwill impairment

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of definite-lived intangible

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total costs and expenses

103,884

115,285

108,568

107,181

87,179

90,931

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

-

-

-

-

-

-

-

-

58,839

50,664

48,358

48,567

41,742

41,570

31,177

20,667

18,527

0

0

0

Loss from operations

-99,513

-111,058

-100,218

-98,696

-80,883

-84,780

-91,648

-89,062

-72,379

-54,361

-58,608

-50,664

-48,358

-48,567

-41,742

-41,570

-31,177

-20,667

-18,527

0

0

0

Other income (expense), net

-2,076

-2,484

-102

882

1,727

2,676

2,867

2,721

2,418

2,070

1,544

1,098

759

488

0

0

0

-

-

-

-

-

Loss from continuing operations

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net loss

-139,375

-161,354

-181,311

-158,732

-140,074

-132,738

-117,121

-102,573

-86,193

-68,523

-57,064

-49,566

-47,599

-48,079

-41,318

-41,256

-30,979

-20,563

-18,506

0

0

0

Accretion of convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,566

2,832

0

0

0

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-23,129

-21,338

0

0

0

Net loss per share, basic and diluted

-0.37

-0.44

-1.34

-1.21

-0.91

-0.98

-1.06

-1.01

-0.98

-0.77

-0.63

-0.56

-0.48

-0.48

-0.50

-0.62

-0.65

4.46

-5.12

-1.52

-1.61

-1.75

Weighted average common shares outstanding, basic and diluted (in shares)

41,618

41,407

41,364

41,274

41,248

38,826

30,982

30,944

30,885

30,899

28,834

26,594

26,080

23,412

21,415

20,663

20,171

17,963

2,274

2,154

2,034

1,794

Other comprehensive income (loss):
Unrealized gain (loss) on marketable securities, net of tax of $0

54

28

75

163

244

145

-17

-19

-134

-121

-32

-107

-89

105

-11

2

-9

-148

4

0

0

0

Foreign currency translation adjustments

42

-25

41

34

35

32

13

-4

55

144

-27

-60

-163

-225

0

0

0

-

-

-

-

-

Total other comprehensive income (loss)

96

3

116

197

279

177

-4

-23

-79

23

-59

-167

-252

-120

-55

1

6

-143

4

0

0

0

Comprehensive loss

-139,279

-161,351

-181,195

-158,535

-139,795

-132,561

-117,125

-102,596

-86,272

-68,500

-57,123

-49,733

-47,851

-48,199

-41,373

-41,255

-30,973

-20,706

-18,502

0

0

0

Product sales
Revenue, net

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract research
Revenue, net

4,153

4,227

4,404

4,539

4,796

4,651

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Other revenue
Revenue, net

0

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-